Laraway Financial Advisors’s Novo Nordisk NVO Stock Holding History

Laraway Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Buy	7,906 +300	+4%	+$12.9K	0.23%	101
2026 Q1	$280K	Sell	7,606 -400	-5%	-$19K	0.2%	113
2025 Q4	$407K	Hold	8,006	–	–	0.27%	81
2025 Q3	$444K	Buy	8,006 +600	+8%	+$35.1K	0.3%	74
2025 Q2	$511K	Hold	7,406	–	–	0.39%	65
2025 Q1	$514K	Hold	7,406	–	–	0.41%	62
2024 Q4	$637K	Hold	7,406	–	–	0.49%	54
2024 Q3	$882K	Hold	7,406	–	–	0.7%	41
2024 Q2	$1.06M	Hold	7,406	–	–	0.9%	33
2024 Q1	$951K	Buy	7,406 +50	+0.7%	+$5.95K	0.84%	34
2023 Q4	$761K	Sell	7,356 -300	-4%	-$29.7K	0.72%	37
2023 Q3	$696K	Sell	7,656 -400	-5%	-$35.2K	0.73%	43
2023 Q2	$652K	Sell	8,056 -600	-7%	-$49K	0.64%	48
2023 Q1	$689K	Buy	+8,656	New	+$614K	0.7%	45

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Laraway Financial Advisors's NVO Position: Q2 2026 in Review

Laraway Financial Advisors increased its Novo Nordisk (NVO) stake by 3.9% in Q2 2026, buying an estimated $12.9K and bringing the position to 7,906 shares worth $379K. The position accounts for 0.23% of the portfolio, ranked #101.

Laraway Financial Advisors first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.06M in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Laraway Financial Advisors held 7,906 shares of Novo Nordisk worth $379K as of Q2 2026.
Laraway Financial Advisors bought 300 Novo Nordisk shares in Q2 2026, an estimated $12.9K.
Novo Nordisk made up 0.23% of Laraway Financial Advisors's portfolio in Q2 2026, its #101 holding.
Laraway Financial Advisors first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
Laraway Financial Advisors's Novo Nordisk position peaked at $1.06M in Q2 2024.
1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.